Advertisement

Topics

Fulcrum SP Ltd. Company Profile

18:19 EDT 23rd September 2018 | BioPortfolio

Established in January 2001 and headquartered in Rehovot, Israel, Fulcrum SP Ltd. is a biotechnological company focused on the research and application of high-performance stable proteins. The company is led by a team of top ranking scientists and business professionals.
Based on a research project that began in 1989 at the Hebrew University of Jerusalem, Fulcrum SP's technology platform is founded on the biochemical mechanism by which plants are protected from stressful conditions. The research led to the discovery of a new class of extremely stable proteins that have the ability to stabilize and repair accompanying proteins.

Location

P.O. Box 3206
Herzliah Pituach
46104
Israel

Contact

Phone: 972 4 999-0478/9
Fax: 972 4 999-0480
Email: info@fulcrumsp.com


News Articles [15 Associated News Articles listed on BioPortfolio]

Fulcrum’s genetic levers

Fulcrum’s use of bioinformatics in small molecule drug discovery led Foresite to lead its $80 million series B round.

Fulcrum raises $80m funding to advance rare disease-focused pipeline

Proceeds from the financing will be used to advance Fulcrum’s lead program in facioscapulohumeral muscular dystrophy (FSHD) into clinical testing, and to progress its pipeline of therapeutics for T...

Working with Patients and a Fresh $80M, Fulcrum Eyes a 2019 IPO

Fulcrum Therapeutics, a Cambridge, MA, startup run by the former CEO of Epizyme, has closed an $80 million Series B round that lays the groundwork for a likely IPO next year, its CEO says. The new fun...

Fulcrum Therapeutics Raises $80 Million Series B From Investors, Including Sanofi and Bill Maris'...

Fulcrum Therapeutics, based in Cambridge, Massachusetts, closed on an $80 million Series B financing.

Fulcrum Therapeutics closes $80mm Series B

Fulcrum Therapeutics Inc. (small molecules for genetic diseases) raised $80mm in its Series B financing led by Foresite Capital, which adds a board member and was joined by Fidelity, 6 Dimensions Capi...

Deals this week: Zealand Pharma, Fulcrum Therapeutics, Forendo Pharma

Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua® and Lyxumia®/Adlyxin® to Royalty Pharma...Read More... The post Deals this week:...

Fulcrum raises $80M series B

Fulcrum Therapeutics Strengthens Board of Directors with Appointment of Kate Haviland

Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies to unlock gene control and treat serious genetic diseases, today announced th...

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

A retrospective controlled clinical study of Cobb angle distribution of the main thoracic curve in adolescent idiopathic scoliosis.

To compare the characteristics of Cobb angle distribution of the main thoracic curve (MTC) in patients with Lenke 1 adolescent idiopathic scoliosis (AIS) and differences in fulcrum-bending flexibility...

The Peritubercle Lucency Sign is a Common and Early Radiographic Finding in Slipped Capital Femoral Epiphysis.

A rotational mechanism of slipped capital femoral epiphysis (SCFE) in which the epiphyseal tubercle acts as a fulcrum has been recently described. However, there is limited radiographic evidence suppo...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

To Evaluate the Robotic Surgery in a Dedicated Multidisciplinary Pediatric Program and the Relative Cost of Robotic Surgery

Robotic minimally invasive surgery has been rapidly adopted for a wide variety of surgical procedures in adult patients across a broad spectrum of surgical specialties. This has occurred d...

Companies [8 Associated Companies listed on BioPortfolio]

Fulcrum Therapeutics

Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients and their families by transforming gene regulation in disease. Fulcrum...

Fulcrum Pharma Developments Inc

Fulcrum Pharma Developments works with biotech and pharmaceutical companies to mitigate the risks associated with drug development. Fulcrum’s development specialists work as an extension of your dev...

Fulcrum SP Ltd.

Established in January 2001 and headquartered in Rehovot, Israel, Fulcrum SP Ltd. is a biotechnological company focused on the research and application of high-performance stable proteins. The company...

Fulcrum Pharma Developments Limited

Fulcrum Pharma is an independent public company that is the first to offer global virtual drug development and strategic outsourcing services to the pharmaceutical and biotechnology industries. Fulcru...

Fulcrum Methods

More Information about "Fulcrum SP Ltd." on BioPortfolio

We have published hundreds of Fulcrum SP Ltd. news stories on BioPortfolio along with dozens of Fulcrum SP Ltd. Clinical Trials and PubMed Articles about Fulcrum SP Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fulcrum SP Ltd. Companies in our database. You can also find out about relevant Fulcrum SP Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record